• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: TERUMO CARDIOVASCULAR SYSTEMS CORPORATION CDI BLOOD PARAMETER MONITORING SYSTEM 550; CARIDOPULMONARY BYPASS ON-LINE BLOOD GAS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

TERUMO CARDIOVASCULAR SYSTEMS CORPORATION CDI BLOOD PARAMETER MONITORING SYSTEM 550; CARIDOPULMONARY BYPASS ON-LINE BLOOD GAS Back to Search Results
Model Number 550AHCT
Device Problem Incorrect, Inadequate or Imprecise Result or Readings (1535)
Patient Problem No Consequences Or Impact To Patient (2199)
Event Type  malfunction  
Event Description
It was reported that during use of the device for a cardiopulmonary bypass (cpb) procedure, the hematocrit (hct) values post in-vivo were approximately six to ten points off from blood gases.The surgical procedure was completed successfully.There was no delay, no blood loss, nor adverse consequences to the patient.It was unknown when this occurred, but about half of the cases between march or april until now, the blood parameter monitor (bpm) has been giving the perfusion team about a six to ten point difference in the hct values.The unit passes its color chip test without issue.They re-invivo the units with the first blood gas, and "hematocrit drift" has been noted.In some instances it was between 6 and 10 points, but in others it does get better with repeated in-vivo calibrations.The unit has not been exchanged out on the cases.There has not been a delay in these surgical procedures, and no blood loss or harm has been reported due to this concern.
 
Manufacturer Narrative
Device evaluated by mfr: 81 - evaluation is in progress, but not yet concluded.
 
Manufacturer Narrative
During laboratory analysis, the product surveillance technician (pst) was able to successfully adjust values, particularly the hematocrit (hct) value, using the in-vivo adjustments throughout the monitor's operating range.The unit operated as intended.
 
Manufacturer Narrative
The reported complaint could not be confirmed.The service repair technician was unable to duplicate the reported complaint.The monitor operated to the manufacturer's specifications.If additional information becomes available on this complaint that would alter the facts and/or conclusion, a supplemental report will be filed accordingly.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
CDI BLOOD PARAMETER MONITORING SYSTEM 550
Type of Device
CARIDOPULMONARY BYPASS ON-LINE BLOOD GAS
Manufacturer (Section D)
TERUMO CARDIOVASCULAR SYSTEMS CORPORATION
6200 jackson road
ann arbor MI 48103
MDR Report Key9382808
MDR Text Key199111239
Report Number1828100-2019-00628
Device Sequence Number1
Product Code DRY
UDI-Device Identifier00886799001790
UDI-Public(01)00886799001790(11)190208
Combination Product (y/n)N
PMA/PMN Number
K182110
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,health
Type of Report Initial,Followup,Followup,Followup
Report Date 04/21/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received11/27/2019
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model Number550AHCT
Device Catalogue Number550AHCT
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer12/10/2019
Was the Report Sent to FDA? No
Date Manufacturer Received03/27/2020
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Treatment
BLOOD GAS ANALYZER
-
-